Abbott's Strong Diabetes Revenue
This is a news story, published by Yahoo Finance, that relates primarily to Abbott news.
Abbott news
For more Abbott news, you can click here:
more Abbott newsmedical innovations news
For more medical innovations news, you can click here:
more medical innovations newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
diabetes sales. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diabetes devices news, overall revenue news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
global diabetes device marketGlobalData
•Health
Health
Abbott US diabetes device sales up 27% amid largely positive Q1

78% Informative
Medtech giant posted an increase in year-over-year overall revenue of 4% , giving total takings of $ 10.36bn .
Shares in the company rose 1% at market open today ( 16 April ) Abbott has a market cap $ 218.9bn .
VR Score
75
Informative language
71
Neutral language
54
Article tone
formal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
1
Affiliate links
no affiliate links